LEXICON PHARMACEUTICALS, INC. SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate
LEXICON PHARMACEUTICALS, INC. (LXRX) had SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate of $11.00 million as of 2020-12-31, per its 10-K filed 2021-03-12.
Discontinued › Notes › Mortgage Loans on Real Estate
us-gaap:MortgageLoansOnRealEstate · last filed 2021-03-12
- 2020-12-31: SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate $11.00M.
- 2019-12-31: SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate $11.00M.
- 2018-12-31: SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate $12.10M.
| Period end | SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate |
|---|---|
| 2020-12-31 | $11.00M 10-K · filed 2021-03-12 |
| 2019-12-31 | $11.00M 10-K · filed 2020-03-12 |
| 2018-12-31 | $12.10M 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |